Free Trial

Plus Therapeutics (PSTV) SEC Filings & 10K Form

Plus Therapeutics logo
$0.37 -0.01 (-3.00%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$0.36 -0.01 (-3.63%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Plus Therapeutics SEC Filings

DateFilerForm TypeView
07/18/2025
3:30 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2025
3:06 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form PRE 14A
06/25/2025
3:22 PM
Hewlett Fund LP (Filed by)
PLUS THERAPEUTICS, INC. (Subject)
Plus Therapeutics (Subject)
Form SCHEDULE 13G/A
06/23/2025
11:15 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form EFFECT
06/23/2025
3:15 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form RW
06/23/2025
8:23 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
06/20/2025
3:16 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
8:51 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form S-1/A
06/17/2025
8:21 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/17/2025
3:25 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025
3:15 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/30/2025
3:20 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2025
2:20 PM
Hewlett Fund LP (Filed by)
PLUS THERAPEUTICS, INC. (Subject)
Plus Therapeutics (Subject)
Form SCHEDULE 13G
05/07/2025
10:59 AM
Petersen Greg (Reporting)
PLUS THERAPEUTICS, INC. (Subject)
Plus Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2025
3:05 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
9:06 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form DEFA14A
04/10/2025
3:11 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form DEF 14A
04/04/2025
3:35 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/01/2025
4:30 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form PRER14A
03/31/2025
3:01 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form RW
03/18/2025
3:17 PM
PLUS THERAPEUTICS, INC. (Subject)
Plus Therapeutics (Subject)
S.H.N. Financial Investments Ltd. (Filed by)
Form SCHEDULE 13G
03/14/2025
4:22 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form PRE 14A
03/10/2025
6:33 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
03/10/2025
6:30 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
4:30 PM
Petersen Greg (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
HEDRICK MARC H (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
van Es-Johansson An (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
Lenk Robert P (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Sims Andrew John Hugh MacIntyre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
Clowes Howard (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
Hawkins Richard J (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
6:30 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
6:32 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
02/10/2025
7:27 AM
HIRSCHMAN ORIN (Filed by)
PLUS THERAPEUTICS, INC. (Subject)
Plus Therapeutics (Subject)
Form SCHEDULE 13G/A
11/01/2024
7:25 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
7:30 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
10/04/2024
3:11 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/17/2024
6:00 AM
Hawkins Richard J (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:00 AM
Hawkins Richard J (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:04 AM
Petersen Greg (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:04 AM
Clowes Howard (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
[No Brainer Gold Play]: “Show me a better investment.” (Ad)

A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Click here to get Garrett’s Top Four picks now.
09/12/2024
3:30 PM
HEDRICK MARC H (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Sims Andrew John Hugh MacIntyre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
Petersen Greg (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
Clowes Howard (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
Hawkins Richard J (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
Lenk Robert P (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
van Es-Johansson An (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
5:02 AM
HEDRICK MARC H (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
5:02 AM
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Sims Andrew John Hugh MacIntyre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:47 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
3:52 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
08/23/2024
3:31 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/15/2024
3:50 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:53 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
08/14/2024
3:48 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PSTV) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners